thuocuytin24h
1+ Views

Nhà thuốc trực tuyến hàng đầu Việt Nam

WebsiteNhà Thuốc Trực Tuyến 24hhttps://thuocuytin.com.vn được đăng ký bởi nhà thuốc việt online đạt chuẩn GPP chuyên cung cấp SỈ & LẺ dược phẩm, thực phẩm chức năng chính hãng, uy tín tại Hà nội, TPHCM và trên toàn quốc . Liên hệ Hotline 0338 814 456 - 0898 814 456. 

SẢN PHẨM VÀ DỊCH VỤ
Thuốc chuyên khoa - Cung cấp các thuốc từ kê đơn đến không kê đơn. Các thuốc thuộc các chuyên khoa : Thần kinh, tim mạch, tiêu hoá, gan, thận, hô hấp, da liễu, nội khoa, ngoại khoa, cơ xương khớp...
Thuốc sinh lý nam - Chúng tôi cung cấp các dược phẩm, thực phẩm chức năng tăng cường chức năng sinh lý ở nam giới, chữa vô sinh, hiếm muộn, yếu sinh lý, rối loạn cương dương, xuất tinh sớm, nâng cao chất lượng tinh trùng.
Thuốc hỗ trợ sinh sản nam và nữ - Thuốc và thực phẩm chức năng làm tăng khả năng sinh sản ở cả nam và nữ. Các dược phẩm tốt nhất trên thị trường, được các y bác sỹ chỉ định điều trị các bệnh hiếm muộn, các bệnh về tinh trùng, buồng trứng.
Bao cao su - Cung cấp các loại bao cao su cao cấp, nhập khẩu chính hãng từ nhà sản xuất.
Thực phẩm chức năng - chăm sóc sức khỏe, làm đẹp, chống oxy hoá.

LIÊN HỆ VỚI NHÀ THUỐC UY TÍN 24H
Truy cập ngay trang web của chúng tôi tại địa chỉ https://thuocuytin.com.vn hoặc kết nối với chúng tôi qua các kênh mạng xã hội:
Twitter         : https://twitter.com/UyThuoc

NHÀ THUỐC UY TÍN 24H
Địa chỉ websitehttps://thuocuytin.com.vn 
Điện thoại: 0338814456 - 0898814456 
Email: cskh.thuocuytin@gmail.com
Đ/c : Văn phòng V8 The Vesta, Phú Lãm, Hà Đông, Hà Nội
Comment
Suggested
Recent
Cards you may also be interested in
Which product & service segment dominates in the High-throughput screening market?
The high-throughput screening (HTS) market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market. The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period. Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950 Market Segmentation: On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research. Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure. Regional Analysis: In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950 Top Key Players:- Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).
Urinary Catheters Market worth $2.6 billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) & Region - Global Forecast To 2025", published by MarketsandMarkets™, the global Urinary Catheters Market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Browse in-depth TOC on "Urinary Catheters Market 125 – Tables 35 – Figures 165 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629 The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market. In 2019, the indwelling catheters segment accounted for the largest share of the urinary catheters market Based on products, the global market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market. The coated catheter segment is expected to grow at the highest CAGR during the forecast period By catheter type, the global market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction. North America was the largest regional market for urinary catheters market in 2019 The market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019. The large share of North America in this market can be attributed to the favorable reimbursement scenario and the rising volume of surgeries in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the growing healthcare spending in emerging Asian countries, rising prevalence of urinary incontinence, and the large target patient population in the region. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132934629 The global urinary catheters market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Other players include Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India). Browse Related Reports: Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/catheters-market-6247803.html
Pharmaceutical Packaging Equipment Market: High growth in generics & biopharmaceuticals markets
The growth of the global pharmaceutical packaging equipment market is driven by the rapidly growing generic & biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, the introduction of regulatory standards on the packaging, and stringent norms against counterfeiting. However, factors such as the adoption of refurbished packaging equipment and the high cost of packaging equipment are expected to restrain market growth to a certain extent during the forecast period. The global pharmaceutical packaging equipment market is projected to reach USD 11.9 Billion by 2027 from USD 8.4 Billion in 2022, at a CAGR of 7.2% from 2022 to 2027. Download PDF Brochure :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828 Market Segmentation: - The primary packaging equipment segment accounted for the largest share of the global market in 2021. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and the sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment. Based on type, the market is segmented into liquid, solid, semi-solid, and other packaging equipment. In 2021, the liquid packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market. The large share of the liquid packaging equipment segment is mainly attributed to the high production of liquid formulations and the increasing incidence of eye and ear disorders across the globe. Regional Analysis: Europe is the largest regional market for pharmaceutical packaging equipment with a share in 2021. Growth in the European market is majorly driven by the high pharm aceutical production, increasing demand for flexible packaging equipment by major pharmaceutical manufacturers, and the rising focus on product diversification by companies, which is driving the demand for innovative packaging equipment. Regulatory changes are also compelling pharmaceutical manufacturers to replace their older equipment with new equipment to adhere to the changing standards. Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=19845828 Top Key Players: - Prominent players in the pharmaceutical packaging equipment market include Robert Bosch GmbH (Syntegon Technology GmbH) (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Coesia S.p.A (Italy), Marchesini Group S.p.A (Italy), Bausch+Ströbel Maschinefabrik Ilshofen GmbH+Co. KG (Germany), Romaco Group (Germany), Uhlmann Group (Germany), Maquinaria Industries Dara, SL (US) and MULTIVAC Group (Germany).
ECG Cables and Lead Wires Market: Increasing prevalence of cardiovascular diseases
Market growth is driven by factors such as rising geriatric population, increasing prevalence of cardiovascular diseases (CVD), technological advancements, and implementation of favorable government regulations in developed countries. The global ECG cables and lead wires market is projected to reach USD 3.0 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 7.5% during the forecast period. Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34598493 Market Segmentation: ECG cables market is segmented into ECG lead wires and ECG cables. The ECG lead wires market is divided into 12-lead ECG lead wires, 5- lead ECG lead wires, 3-lead ECG lead wires, 6-lead ECG lead wires, single-lead ECG lead wire, and other ECG lead wires (15- and 18-lead ECG lead wires). In 2020, the 12-lead ECG lead wires segment accounted for the largest share of the ECG lead wires and ECG cables market. The large share of this segment can be attributed to the wide usage by paramedics to diagnose acute myocardial infarction (AMI) and reduce treatment time. ECG cables and lead wires market is segmented into TPE (thermoplastic elastomer), TPU (thermoplastic polyurethane), and other materials (silicone and PVC). In 2020, the TPE segment accounted for the largest share of the ECG cables and lead wires. The large share of this segment can be attributed to the increased consistency, durability, shore hardness, and flexibility offered compared to other materials. ECG cables market is segmented into reusable and disposable cables and lead wires. In 2020, the reusable cables and lead wires segment accounted for the largest share of the ECG cables and lead wires market. The huge share of this segment is mainly due to the low prices associated with the adoption of reusable cables and lead wires and because these types are majorly adopted in the developing regions. Based on patient care setting, the lead wires market is segmented hospitals & ICUs, long-term care facilities, clinics, and ambulatory and home care centers. In 2020, hospitals & ICUs accounted for a larger share of the ECG cables and lead wires market. The large share of this segment can be attributed to the growing burden of cardiovascular diseases, which in turn is increasing the need for quality cardiology care. Regional Analysis: The global ECG cables market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the market. The North American lead wires market growth can be attributed to the rapid increase in the aging population and rising cardiovascular disease rate as compared to other regions. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=34598493 Top Key Players: The major players operating in this ECG Cables and Lead Wires Market are Cardinal Health, Inc. (US), 3M Company (US), Becton, Dickinson and Company (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott Laboratories (US), Boston Scientific Corporation (US), CONMED Corporation (US), OSI Systems, Inc. (US), Mindray Medical International Limited (China), Welch Allyn, Inc. (US), Curbell Medical Products, Inc. (US), Schiller AG (US), Siemens Healthineers AG (Germany), Dräger (Germany), Shanghai Berry Electronic Tech Co., Ltd (China), Unimed Medical Supplies Inc. (China), Amydi-med Electronic Technology Co., Ltd. (China), MedLink Electronics Tech Co. Ltd., (China), Sorimex (Poland), Nuova Gmbh (Germany), LUMED (Italy), UpnMed Equipment Co., Ltd.(China), Carlisle Medical Technologies (US), and LifeLine Medical, Inc. (US).
Ophthalmic Surgical Instruments Market to Expand at a Healthy Growth Rate in the Coming Years
The ophthalmic surgical instruments market is segmented into femtosecond lasers, excimer lasers, other lasers, and refractive surgery instruments & kits. The femtosecond lasers segment accounted for the major share of the refractive surgery devices market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment is attributed to its benefits such as lower incidence of dry eyes, less induced aberrations, greater safety, faster uncorrected visual acuity recovery, less intraocular pressure (IOP) variation in the femtosecond-created flap, and growing number of femtosecond laser-assisted surgeries being performed across the globe. What the Market Looks Like? The global Ophthalmic surgical instruments market is projected to reach USD 11.18 Billion by 2022 from USD 8.36 Billion in 2017, at a CAGR of 6.0%. Based on product, the ophthalmology surgical instruments market is segmented into cataract surgery devices, vitreoretinal surgery devices, refractive surgery devices, glaucoma surgery devices, ophthalmic microscopes, and accessories. The cataract surgery devices segment accounted for the major share of the global ophthalmic surgical instruments market. The large share of this segment can primarily be attributed to the growing number of cataract surgeries across the globe. Glaucoma surgery devices segment is expected to register the highest growth during the forecast period. The high growth of this segment is attributed to the rising prevalence of glaucoma and technological advancements in the glaucoma surgical devices throughout the world. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11819932 What Drives the Market? The growth of the global market for Ophthalmic Surgical Instruments is primarily influenced by the following factors: · Rising Prevalence of Eye Diseases · Technological Advancements in Ophthalmic Surgical Instruments · Increasing Government Initiatives to Control Visual Impairment North America accounted for the largest share of the ophthalmology surgical instruments market in 2016, followed by Europe. The large share of this region is attributed to rising prevalence of ocular disorders owing to growing geriatric population in North America, increase in healthcare expenditure, technological advancements in instruments & devices used for minimally invasive surgeries, and increasing regulatory approvals. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=11819932 Top Key Players: - The prominent players in the global ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).
Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Surgical Robots Market by Product & Service (Instruments & Accessories, Systems, Service), Application (Urological Surgery, Gynecological Surgery, Orthopedic Surgery), End User (Hospitals, Ambulatory Surgery Center) - Analysis and Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 14.4 billion by 2026 from an estimated USD 6.4 billion in 2021, at a CAGR of 17.6%. Browse in-depth TOC on "Surgical Robots Market" 212 – Tables 35 – Figures 220 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532 The Growth in this market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and increased funding for medical robot research. The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World. The COVID-19 pandemic has had a devastating global impact on the world's population and economy. The pandemic has put a significant strain on healthcare systems. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to minimize the possibility of transmission and conserve healthcare resources for COVID-19 patients. The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in the cancellations of elective surgeries worldwide posing a negative impact on the globe. Instruments and Accessories to account for the largest share in the market Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services. The instruments & accessories segment commanded the largest share of 53.8% of the market in 2020. This segment is also expected to grow at the highest CAGR of 18.2% during the forecast period. The large share and high growth rate of this segment are mainly driven by the recurrent purchase of instruments & accessories instead of robotic systems, which are a one-time investment. General surgery to account for the fastest growing application in the market Based on application, the surgical robots market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment commanded the largest share of 29.5% of the market in 2020. This segment is also projected to register the highest CAGR of 18.2% during the forecast period. Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532 Asia Pacific to Witness highest growth from 2021 to 2026 North America dominated the surgical robots market, with a share of 63.6% in 2019, while the Asia Pacific region is expected to register the highest CAGR of 18.5% during the forecast period. The large share of the North American market can be attributed to the availability of funding for R&D in surgical robots in this region and the increasing adoption of surgical robots for pediatric surgeries in Canada and general surgery procedures in the US. Some of the prominent players operating in the Surgical robots market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (Transenterix) (US), Corindus Vascular Robotics (US), Renishaw (UK), Auris Health (US), Medrobotics Corporation (US), Think Surgical (US), Verb Surgical (US), OMNIlife Science (US), CMR Surgical (US), Preceyes BV (Netherlands), China National Scientific Instruments And Materials Corporation (CSIMC) (China), Microsure (Netherlands), Titan Medical (Canada), avateramedical Gmbh (Germany) and Medicaroid Corporation (Japan).
Animal Growth Promoters and Performance Enhancers Market worth $21.4 billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Browse in-depth TOC on "Animal Growth Promoters and Performance Enhancers Market" 118 – Tables 53 – Figures 245 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167 Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period. By Type, the non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=137134167 On the basis of animal type, poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market The poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives. Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers. Prominent players in the Animal Growth Promoters and Performance Enhancers Market include are Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd. (South Africa) and Novus International, Inc. (US). Browse Related Reports: Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.html